Stem cell transplantation in amyotrophic lateral sclerosis patients: Methodological approach, safety, and feasibility

Cell Transplantation

Volumn 21, Issue 9, 2012, Pages 1899-1907

  Martínez, Héctor R ^a,b,c   Molina Lopez, Juan Francisco ^b   González Garza, María Teresa ^b   Moreno Cuevas, Jorge E ^b   Caro Osorio, Enrique ^a,b   Gil Valadez, Alfonso ^b   Gutierrez Jimenez, Eugenio ^b   Zazueta Fierro, Oscar E ^b   Alfonso Meza, J ^b   Couret Alcaraz, Patricio ^b   Hernandez Torre, Martin ^b  

^a Hospital San Jose Tec de Monterrey   (Mexico)

^b SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

ALS; Safety; Stem cell; Transplant

Indexed keywords

CD133 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BONE MARROW; CELL ISOLATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEATH; FEASIBILITY STUDY; HEADACHE; HUMAN; INFORMED CONSENT; LABORATORY TEST; LEUKAPHERESIS; LONG TERM SURVIVAL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MOTOR CORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATIENT SAFETY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCALP PAIN; SKIN PAIN; STEM CELL TRANSPLANTATION;

AMYOTROPHIC LATERAL SCLEROSIS; FEASIBILITY STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKAPHERESIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; MOTOR CORTEX; RECOMBINANT PROTEINS;

EID: 84869742367     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X582769     Document Type: Article

References (42)

1. Aejaz, H. M.; Aleem, A. K.; Parveen, N.; Khaja, 1. M. N.; Narusu, M. L.; Habibullah, C. M. Stem cell therapy-present status. Transplant. Proc. 39:694-699; 2007.
2. Appel, S. H.; Engelhardt, J. I.; Henkel, J. S.; Siklos, L.; Beers, D. R.; Yen, A. A.; Simpson, E. P.; Luo, Y.; Carrum, G.; Heslop, H. E.; Brenner, M. K.; Popat, U. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 71:1326-1334; 2008.
3. + cell grafts in stroke rats. Brain Res. 1048:116-122; 2005.
4. Brooks, B. R.; Miller, R. G.; Swash, M.; Munsat, T. L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1:293-299; 2000.
5. Cashman, N.; Tan, L. Y.; Krieger, C.; Mädler, B.; Mackay, A.; Mackenzie, I.; Benny, B.; Nantel, S.; Fabros, M.; Shinobu, L.; Yousefi, M.; Eisen, A. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve 37:620-625; 2008.
6. Cho, K. J.; Trzaska, T.; Greco, S. J.; McArdle, J.; Wang, F. S.; Ye, J. H.; Rameshwar, P. Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 23:383-391; 2005.
7. Choumerianou, D. M.; Dimitriou, H.; Kalmanti, M. Stem cells: Promises versus limitations. Tissue Eng. Part B Rev. 14:53-60; 2008.
8. Deda, H.; Inci, M. C.; Kürekçi, A. E.; Sav, A.; Kayihan, K.; Ozgün, E.; Ustünsoy, G. E.; Kocabay, S. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: A 1-year follow-up. Cytotherapy 11:18-25; 2009.
9. Delcroix, G. J.; Schiller, P. C.; Benoit, J. P.; Montero-Menei, C. N. Adult cell therapy for brain neuronal damage and the role of tissue engineering. Biomaterials 31:2105-2120; 2010.
10. Hashimoto, H.; Itoh, M.; Nishimura, M.; Asai, T. Effect of filgrastim for steady-state mobilization of peripheral blood stem cells. Ther. Apher. 6:431-436; 2002.
11. Huang, H.; Chen, L.; Sanberg, P. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med. 1:15-46; 2010.
12. Hung, S. C.; Cheng, H.; Pan, Y. P.; Tsai, M. J.; Kao, L. S.; Ma, H. L. In vitro differentiation of size-sieved stem cells into electrically active neural cells. Stem Cells 20:522-529; 2002.
13. Issacson, O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol. 2:417-423; 2003.
14. Janson, C. G.; Ramesh, T. M.; During, M. J.; Leone, P.; Heywood, J. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. J. Hematother. Stem Cell Res. 10:913-915; 2001.
15. John, J. Grading of muscle power: Comparison of MRC and analogous scales by physiotherapists. Int. J. Rehab. Res. 7:173-181; 1984.
16. Jozwiak, S.; Habich, A.; Kotulska, K.; Sarnowska, A.; Kropiwnicki, T.; Janowski, M.; Jurkiewicz, E.; Lukomska, B.; Kmiec, T.; Walecki, J.; Roszkowski, M.; Litwin, M.; Oldak, T.; Boruczkowski, D.; Domanska-Janik, K. Intracerebroventricular transplantation of cord bloodderived neural progenitors in a child with severe global brain ischemic injury. Cell Med. 1:71-80; 2010.
17. Kaufmann, P.; Levy, G.; Thompson, J. L. P.; DelBene, M. L. The ALSFRS-R predicts survival time in an ALS clinic population. Neurology 64:39-43; 2005.
18. Kim, S. U.; de Vellis, J. Stem cell-based cell therapy in neurological diseases: A review. J. Neurosci. Res. 87:2183-2200; 2009.
19. Kondziolka, D.; Wechsler, L.; Goldstein, S.; Meltzer, C.; Thulborn, K. R.; Gebel, J.; Jannetta, P.; DeCesare, S.; Elder, E. M.; McGrogan, M.; Reitman, M. A.; Bynum, L. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55:565-569; 2000.
20. Kröger, N.; Renges, H.; Krüger, W.; Gutensohn, K.; Löliger, C.; Carrero, I.; Cortes L.; Zander, A. R. A randomized comparison of once versus twice daily recombinant human granulocyte colony stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br. J. Haematol. 111:761-765; 2000.
21. Levy, Y. S.; Stroomza, M.; Melamed, E.; Offen, D. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease. J. Mol. Neurosci. 24:353-379; 2004.
22. Lima, C.; Pratas-Vital, J.; Escada, P.; Hasse-Ferreira, A.; Capucho, C.; Peduzzi, J. D. Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J. Spinal Cord Med. 29:191-203; 2006.
23. Lomen-Hoerth, C. Amyotrophic lateral sclerosis from bench to bedside. Semin. Neurol. 28:205-211; 2008.
24. Long, X.; Olszewski, M.; Huang, W.; Kletzel, M. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev. 14:65-69; 2005.
25. Martinez, H. R.; Gonzalez-Garza, M. T.; Moreno-Cuevas, J.; Caro, E.; Gutierrez-Jimenez, E.; Segura, J. J. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 11:26-34; 2009.
26. Martinez, H. R.; Molina-Lopez, J. F.; Cantu-Martinez, L.; Gonzalez-Garza, M. T.; Moreno-Cuevas, J. E.; Couret-Alcaraz, P.; Treviño, S. A.; Webb-Vargas, Y.; Caro, E.; Gil-Valadez, A.; Santos-Guzmán, J.; Hernandez-Torre, M. Survival and clinical features in hispanic amyotrophic lateral sclerosis patients. Amyotroph. Lateral Sc. 12: 199-205; 2011.
27. Mazzini, L.; Ferrero, I.; Luparello, V.; Rustichelli, D.; Gunetti, M.; Mareschi, K.; Testa, L.; Stecco, A.; Tarletti, R.; Miglioretti, M.; Fava, E.; Nasuelli, N.; Cisari, C.; Massara, M.; Vercelli, R.; Oggioni, G. D.; Carriero, A.; Cantello, R.; Monaco, F.; Fagioli, F. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A phase I clinical trial. Exp. Neurol. 223:229-237; 2010.
28. Miller, R. G.; Munsat, T. L.; Swash, M.; Brooks, B. R. Consensus guidelines for the design and implementation of clinical trial in ALS. World Federation of Neurology Committee on Research. J. Neurol. Sci. 169:2-12; 1999.
29. Mills, K. R. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain 126:2558-2566; 2003.
30. Moviglia, G. A.; Fernandez Vina, R.; Brizuela, J. A.; Saslavsky, J.; Vrsalovic, F.; Varela, G.; Bastos, F.; Farina, P.; Etchegaray, G.; Barbieri, M.; Martinez, G.; Picasso, F.; Schmidt, Y.; Brizuela, P.; Gaeta, C. A.; Costanzo, H.; Moviglia, Brandolino, M. T.; Merino, S.; Pes, M. E.; Veloso, M. J.; Rugilo, C.; Tamer, I.; Shuster, G. S. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy 8:202-209; 2006.
31. National Cancer Institute; U.S. National Institutes for Health. Common Terminology Criteria for Adverse Events. http:// ctep.cancer.gov/MajorInitiatives/Common_Terminology_ Criteria.htm; accessed Aug 31; 2010.
32. Ravits, J. M.; La Spada, A. R. ALS motor phenotype heterogeneity, focality, and spread. Deconstructing motor neuron degeneration. Neurology 73:805-811; 2009.
33. Ringel, S. P.; Murphy, J. R.; Alderson, M. K.; Bryan, W.; England, J. D.; Miller, R. G.; Petajan, J. H.; Smith, S. A.; Roelofs, R. I.; Ziter, F. Natural history of amyotrophic lateral sclerosis. Neurology 43:1316-1322; 1993.
34. Rowland, L. P.; Schneider, N. A. Amyotrophic lateral sclerosis. N. Eng. J. Med. 344:1688-1700; 2001.
35. Sawaya, R.; Hammoud, M.; Shoppa, D.; Hess, K. R.; Wu, S. Z.; Shi, W. M.; Wildrick, D. M. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044-1056; 1998.
36. Schwarz, S. C.; Schwarz, J. Translation of stem cells therapy for neurological diseases. Transl. Res. 156:155-160; 2010.
37. Silani, V.; Coba, L.; Corbo, M.; Ciammola, A.; Polli, E. Stem cell therapy for amyotrophic lateral sclerosis. Lancet 363:200-202; 2004.
38. Toft, M. H.; Gredal, O.; Pakkenberg, B. The size 38. distribution of neurons in the motor cortex in amyotrophic lateral sclerosis. J. Anat. 207:399-407; 2005.
39. + cells from human peripheral blood promote corticospinal axon regeneration. Neuroreport 19:799-803; 2008.
40. Zhong, Z.; Deane, R.; Ali, Z.; Parisi, M.; Shapovalov, Y.; O'Banion, M. K.; Stojanovic, K.; Sagare, A.; Boillee, S.; Cleveland, D. W.; Zlokovic, B. V. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 11:420-422; 2008.
41. Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57(2):178-201; 2008.
42. Zoccolella, S.; Beghi, E.; Palagano, G. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: A population based study. J. Neurol. Neurosurg. Psychiatry 79:33-37; 2008.